Lykis Limited (LYKISLTD) Fair Value & Analysis
Consumer Defensive · IN · Market cap ₹862M
Fair value as of: Jul 5, 2026
From 15 valuation models · updated today
Share price −4.6% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹30.44 – ₹55.79 · fair‑value band ₹42.61 – ₹79.77 · the ₹44.50 price screens below the ₹56.81 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Lykis Limited (LYKISLTD) currently trades at ₹44.50, while our model-based Fair Value estimate is ₹56.81 — implying the stock looks roughly 27.7% undervalued today. We read business quality at 50/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Lykis Limited generated revenue of ₹3.9B at a net margin of 1.7%. Revenue grew 136.6% year over year. It earns a return on equity of 17.3%. Net debt stands at ₹978M. Fundamentals as of Jul 5, 2026
Our scenario range runs from ₹42.61 (bear case) to ₹79.77 (bull case); at ₹44.50, the current price sits within that range. The share trades about 28% below its 52-week high and 52% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -36% fair-value upside — at 28%, LYKISLTD screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
About the company
Lykis Limited engages in the fast moving consumer goods (FMCG) business in India and internationally. The company provides personal care products including skin care products, such as creams, face wash, body oil, lotion, shower gel, masks, face and body scrub, hair removal cream, petroleum jelly, body butter, talc, intimate wash, petroleum jelly, and hand wash; hair care products comprising shampoo, spray, conditioner, base cream, hair food and relaxer, oil, detox mask, cleansing liquid, hair colour and milk, pomade, and gels; toothpaste; soaps; deodorant, perfume, and body mist; and baby cream, oil, shampoo, talc, wipes, and diaper. It also offers FMCG products, including biscuits and cookies; confectionery, such as candy, lollipops, and toffees; commodity products comprising hot pots, stock pots, utensils, footwear, liquor, and others; and other OTC products. The company provides its products under the Lykis, H&H, Rox, Bonita, Monami, Special, Lykon, Bentol, Stylo, Bon Fami, …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Lykis Limited reported revenue of ₹3.9B in FY2026 versus ₹3.2B in FY2022, a compound +4.7%/yr. Reported net income was ₹64.8M in FY2026, compounding +27.9%/yr from FY2022.
Is LYKISLTD fairly valued? → Check now
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 5, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | 2,590 MXN | 1,415 MXN | -45% |
| L'Oréal S.A LRLCF | $428.02 | $273.79 | -36% |
| Unilever PLC UNLYF | $59.34 | $46.11 | -22% |
| Colgate-Palmolive Company CPA | €79.16 | €55.96 | -29% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,170 | ₹807.38 | -63% |
| Reckitt Benckiser Group RBGLY | $12.41 | $17.31 | +39% |
| Henkel AG HENOY | $20.52 | $20.98 | +2% |
| Kimberly-Clark Corporation KMBB34 | R$530.90 | R$72.97 | -86% |
| Kenvue Inc KVUE | $18.05 | $11.24 | -38% |
| Church & Dwight Co CHDC34 | R$488.56 | R$53.25 | -89% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Lykis Limited (LYKISLTD) undervalued?
What is the fair value of LYKISLTD?
What is the quality score of LYKISLTD?
What is the revenue of Lykis Limited (LYKISLTD)?
What is the net profit margin of LYKISLTD?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.